The Lilly company has developed a new therapeutic option to improve the glycemic control of people with type 2 diabetes that consists of a unique injection device with the aim of simplifying the management of diabetes and reducing the time that nurses need to educateHis patients in the use of injectables.
The new injectable treatments are directed precisely to reduce these inconveniences and thus improve the experience, with a simpler and more comfortable administration for the patient.Therefore, Lilly has created an already prepared pen and with the needle pre -instead to be administered with a single use.
"This pen gets the patient to feel calmer when medicating;The Diabetes Unit of the Endocrinology and Nutrition Service of the Clinical Hospital of Barcelona, Mercé Vidal.
With this, "the tension that some people feel with injectable treatments is eliminated; it is not necessary to pinch to look for the best puncture area because the device is really easy to use: it is placed on the skin and with a 'click'It is injected alone and then throws, "he details.
How to use the device
The first step is to uncover the pen, place it on the skin and unlock it and then press the injection button while the device is fastened for 5 or 10 seconds.Finally, the pen is removed and discarded.
This simplicity allows "that we can devote more time to helping the patient to change their life habits as an essential complement in pharmacological treatment; habits that mainly go through a healthy diet and adequate physical activity."
"The fact that it is administered weekly and that its use is so simple offers enough flexibility for patients. In addition, the weekly administration, logically, also reduces the number of injections against other daily injectable treatments," the nurse concluded.
The first results indicate that 99 percent of prior experienced patients have considered this "easy to use" device.After three injections, 96.7 percent of the participants in the Lilly survey were willing to continue the treatment.
